Sui Weiguo, Zheng Can, Yang Ming, Dai Yong
Guilin 181st Hospital, Guilin, Guangxi, China.
Guangxi Normal University, Guilin, Guangxi, China.
Prog Transplant. 2014 Dec;24(4):375-80. doi: 10.7182/pit2014730.
Development of effective immunosuppressive agents and advances in surgical practice are the main reasons for the success of transplantation in China. In some key areas such as liver, lung, and kidney transplants, Chinese transplant success rates are similar to the rates in developed countries. Organ donation also has developed rapidly. However, China is facing a serious organ shortage that restricts clinical treatment and medical research. This shortage is due to imperfect laws and improper management of organ donation, as well as Chinese traditional ethics. Finding an efficient way to make the number of donated organs keep pace with the need for organ transplants and to optimize allocation of organ resources is a long-term and arduous task. In some ways, Chinese organ donation nowadays is constrained more by legal issues than by medical issues. The current status of and challenges facing organ donation in China are analyzed with respect to ethics, management, laws, and policy, and the future development of transplantation in China is discussed.
有效的免疫抑制剂的研发以及外科手术实践的进步是中国移植手术成功的主要原因。在肝脏、肺和肾脏移植等一些关键领域,中国的移植成功率与发达国家相近。器官捐献也发展迅速。然而,中国正面临严重的器官短缺问题,这限制了临床治疗和医学研究。这种短缺是由于法律不完善、器官捐献管理不当以及中国传统伦理观念所致。找到一种有效的方法,使捐献器官的数量与器官移植的需求相匹配,并优化器官资源的分配,是一项长期而艰巨的任务。在某些方面,如今中国的器官捐献更多地受到法律问题的制约,而非医学问题。本文从伦理、管理、法律和政策等方面分析了中国器官捐献的现状与挑战,并探讨了中国移植手术的未来发展。